171 related articles for article (PubMed ID: 11746261)
1. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer.
Dong JT; Boyd JC; Frierson HF
Prostate; 2001 Nov; 49(3):166-71. PubMed ID: 11746261
[TBL] [Abstract][Full Text] [Related]
2. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
[TBL] [Abstract][Full Text] [Related]
3. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
[TBL] [Abstract][Full Text] [Related]
4. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.
Jongsma AP; Piek JM; Zweemer RP; Verheijen RH; Klein Gebbinck JW; van Kamp GJ; Jacobs IJ; Shaw P; van Diest PJ; Kenemans P
Mol Pathol; 2002 Oct; 55(5):305-9. PubMed ID: 12354934
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
6. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer.
Afonso A; Emmert-Buck MR; Duray PH; Bostwick DG; Linehan WM; Vocke CD
J Urol; 1999 Sep; 162(3 Pt 1):922-6. PubMed ID: 10458409
[TBL] [Abstract][Full Text] [Related]
8. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer.
Latil A; Bièche I; Pesche S; Volant A; Valèri A; Fournier G; Cussenot O; Lidereau R
Hum Pathol; 1999 Jul; 30(7):809-15. PubMed ID: 10414500
[TBL] [Abstract][Full Text] [Related]
10. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss on 13q in esophageal squamous cell carcinomas from northern China.
Huang XP; Wei F; Liu XY; Xu X; Hu H; Chen BS; Xia SH; Han YS; Han YL; Cai Y; Wu M; Wang MR
Cancer Lett; 2002 Nov; 185(1):87-94. PubMed ID: 12142083
[TBL] [Abstract][Full Text] [Related]
12. CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.
Latil A; Morant P; Fournier G; Mangin P; Berthon P; Cussenot O
Int J Cancer; 2002 Jun; 99(5):689-96. PubMed ID: 12115502
[TBL] [Abstract][Full Text] [Related]
13. Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues.
Mutirangura A; Charuruks N; Shuangshoti S; Sakdikul S; Chatsantikul R; Pornthanakasem W; Sriuranpong V; Supiyaphun P; Voravud N
Int J Cancer; 1999 Oct; 83(2):210-4. PubMed ID: 10471529
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Sipe TW; Li CL; Degeorges A; Sikes RA; Chung LW; Dong JT
Prostate; 1999 Nov; 41(3):190-5. PubMed ID: 10517877
[TBL] [Abstract][Full Text] [Related]
16. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
18. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
Ittmann MM
Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
[TBL] [Abstract][Full Text] [Related]
20. [Loss of heterozygosity on chromosome 13 in squamous cell carcinomas of the larynx].
Bai S; Zhang X; Wang J
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):35-7. PubMed ID: 10743052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
